could easily be a $200M+ company with IND approved and Orphan drug designation as well as another IND in the hopper with MIN tech! No doubt in my mind whatsoever....that would be .085 to .11 range at 2.3B o/s.
who needs infrastructure and employees if BIG PHARMA buys them out for .25 to $1.00 per share? BIG PHARMA = BIG MONEY...this is next generation science we're talking about here!